We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Research Article

Near-infrared enhances antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in breast cancer stem cells via deregulation of HSP-70/TGF-β

    Somya Ranjan Dash

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    ,
    Biswajit Das

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    ,
    Chinmay Das

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    ,
    Saptarshi Sinha

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    ,
    Subarno Paul

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    ,
    Rajalaxmi Pradhan

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    &
    Chanakya Nath Kundu

    *Author for correspondence: Tel.: +91 674 272 5466;

    E-mail Address: cnkundu@kiitbiotech.ac.in

    Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Bhubaneswar, Odisha, 751024, India

    Published Online:https://doi.org/10.2217/nnm-2022-0243

    Aim: This study aimed to explore the antiangiogenic mechanism of quinacrine-gold hybrid nanoparticle (QAuNP) and near-infrared (NIR) radiation in patient-derived primary breast cancer stem cells. Materials & methods: Various cell-based in ovo angiogenesis and in vivo patient-derived xenograft mouse systems were used as models for the study. Results: The experimental results showed that QAuNP + NIR treatment deregulated the HSP-70/TGF-β physical interaction in primary breast cancer stem cells. Reduced TGF-β secretion in the tumor microenvironment inhibited angiogenesis activation in endothelial cells by deregulating the TGF-β-mediated PI3K/AKT/mTOR cascade. Conclusion: This study revealed that QAuNP + NIR irradiation downregulated HSP-70 expression, inhibited the HSP-70/TGF-β interaction, reduced the secretion of TGF-β in the tumor microenvironment and ultimately inhibited TGF-β-mediated angiogenesis.

    Graphical abstract

    Plain language summary

    This study discovered that the formation of blood vessels in breast cancer is significantly reduced when hybrid nanoparticles and infrared laser therapy are used to treat breast cancer stem cells. The secretory cytokines in the tumor microenvironment primarily responsible for developing blood vessels in the tumor are dramatically reduced by treatment. As a result, the tumor's blood vessel growth is reduced, making it difficult for the cancer cells to get the nutrients and oxygen they need to survive.

    Tweetable abstract

    Near-infrared radiation enhances the antiangiogenic potentiality of quinacrine-gold hybrid nanoparticles in patient-derived breast cancer stem cells via deregulation of the HSP-70/TGF-β axis.

    Papers of special note have been highlighted as: • of interest

    References

    • 1. Sung H, Ferlay J, Siegel RL et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209–249 (2021).
    • 2. Madu CO, Wang S, Madu CO, Lu Y. Angiogenesis in breast cancer progression, diagnosis, and treatment. J. Cancer 11(15), 4474–4494 (2020). • Highlights the mechanism of angiogenesis in diseases and its role in the progression of malignancy in breast cancer.
    • 3. Al-Ostoot FH, Salah S, Khamees HA, Khanum SA. Tumor angiogenesis: current challenges and therapeutic opportunities. Cancer Treat. Res. Commun. 28, 100422 (2021). • Provides an overview of concepts of tumor angiogenesis and several important angiogenic factors as well as focuses on the role of antiangiogenesis strategies in cancer treatment.
    • 4. Nishida N, Yano H, Nishida T, Kamura T, Kojiro M. Angiogenesis in cancer. Vasc. Health Risk Manag. 2(3), 213 (2006).
    • 5. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3), 309–322 (2012).
    • 6. Kim HJ, Ji YR, Lee YM. Crosstalk between angiogenesis and immune regulation in the tumor microenvironment. Arch. Pharm. Res. 45(6), 1–16 (2022).
    • 7. López de Andrés J, Griñán-Lisón C, Jiménez G, Marchal JA. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J. Hematol. Oncol. 13(1), 1–22 (2020).
    • 8. Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J. Biomed. Sci. 25(1), 1–18 (2018).
    • 9. Zhao Y, Bao Q, Renner A et al. Cancer stem cells and angiogenesis. Int. J. Dev. Biol. 55(4–5), 477–482 (2011).
    • 10. Baba AB, Rah B, Bhat GR et al. Transforming growth factor-beta (TGF-β) signaling in cancer – a betrayal within. Front. Pharmacol. 13 (2022). • Findings showed the dual role of TGF-β under different cellular conditions and its crosstalk with other signaling pathways in modulating cell fate and angiogenesis.
    • 11. Liu S, Chen S, Zeng J. TGF-β signaling: a complex role in tumorigenesis. Mol. Med. Rep. 17(1), 699–704 (2018).
    • 12. Quintero-Fabián S, Arreola R, Becerril-Villanueva E et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front. Oncol. 9, 1370 (2019).
    • 13. Elice F, Rodeghiero F. Side effects of anti-angiogenic drugs. Thromb. Res. 129, S50–S53 (2012).
    • 14. Alsaab HO, Al-Hibs AS, Alzhrani R et al. Nanomaterials for antiangiogenic therapies for cancer: a promising tool for personalized medicine. Int. J. Mol. Sci. 22(4), 1631 (2021).
    • 15. Jang J, Kim MR, Kim T-K et al. CLEC14a-HSP70-1A interaction regulates HSP70-1A-induced angiogenesis. Sci. Rep. 7(1), 1–12 (2017).
    • 16. Park SL, Chung T-W, Kim S et al. HSP70-1 is required for interleukin-5-induced angiogenic responses through eNOS pathway. Sci. Rep. 7(1), 1–14 (2017). • First study that showed VEGF independent angiogenesis.
    • 17. Dash SR, Chatterjee S, Sinha S et al. NIR irradiation enhances the apoptotic potentiality of quinacrine-gold hybrid nanoparticles by modulation of HSP-70 in oral cancer stem cells. Nanomedicine 40, 102502 (2022).
    • 18. Das B, Kundu CN. Anti-cancer stem cells potentiality of an anti-malarial agent quinacrine: an old wine in a new bottle. Anti-Cancer Agents Med. Chem. 21(4), 416–427 (2021).
    • 19. Chatterjee S, Kundu CN. Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells. Eur. J. Pharmacol. 883, 173308 (2020).
    • 20. Neznanov N, Gorbachev AV, Neznanova L et al. Anti-malaria drug blocks proteotoxic stress response: anti-cancer implications. Cell Cycle 8(23), 3960–3970 (2009).
    • 21. Dash SR, Kundu CN. Photothermal therapy: a new approach to eradicate cancer. Curr. Nanosci. 18(1), 31–47 (2022).
    • 22. Mukherjee P, Bhattacharya R, Wang P et al. Antiangiogenic properties of gold nanoparticles. Clin. Cancer Res. 11(9), 3530–3534 (2005).
    • 23. Hembram KC, Dash SR, Das B et al. Quinacrine based gold hybrid nanoparticles caused apoptosis through modulating replication fork in oral cancer stem cells. Mol. Pharm. 17(7), 2463–2472 (2020).
    • 24. Sethy C, Goutam K, Das B, Dash SR, Kundu CN. Nectin-4 promotes lymphangiogenesis and lymphatic metastasis in breast cancer by regulating CXCR4-LYVE-1 axis. Vascul. Pharmacol. 140, 106865 (2021).
    • 25. Chatterjee S, Sinha S, Molla S, Hembram KC, Kundu CN. PARP inhibitor veliparib (ABT-888) enhances the anti-angiogenic potentiality of curcumin through deregulation of NECTIN-4 in oral cancer: role of nitric oxide (NO). Cell Signal. 80, 109902 (2021).
    • 26. Pradhan R, Chatterjee S, Hembram KC, Sethy C, Mandal M, Kundu CN. Nano formulated resveratrol inhibits metastasis and angiogenesis by reducing inflammatory cytokines in oral cancer cells by targeting tumor associated macrophages. J. Nutr. Biochem. 92, 108624 (2021).
    • 27. Siddharth S, Nayak A, Das S et al. The soluble nectin-4 ecto-domain promotes breast cancer induced angiogenesis via endothelial Integrin-β4. Int. J. Biochem. Cell Biol. 102, 151–160 (2018).
    • 28. Ricardo S, Vieira AF, Gerhard R et al. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J. Clin. Pathol. 64(11), 937–946 (2011).
    • 29. Brugnoli F, Grassilli S, Al-Qassab Y, Capitani S, Bertagnolo V. CD133 in breast cancer cells: more than a stem cell marker. J. Oncol. 2019, 1–8 (2019).
    • 30. Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J. Immunol. Res. 2014, 1 –19 (2014).
    • 31. Anderson NM, Simon MC. The tumor microenvironment. Curr. Biol. 30(16), R921–R925 (2020).
    • 32. Jiang X, Wang J, Deng X et al. The role of microenvironment in tumor angiogenesis. J. Exp. Clin. Cancer Res. 39(1), 1–19 (2020).